Acasti Total Current Liabilities from 2010 to 2024
| ACST Stock | USD 2.73 0.03 1.11% |
Total Current Liabilities | First Reported 2009-09-30 | Previous Quarter 1.4 M | Current Value 1.8 M | Quarterly Volatility 3.2 M |
Check Acasti Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acasti main balance sheet or income statement drivers, such as Depreciation And Amortization of 106 K, Interest Expense of 81.7 M or Other Operating Expenses of 12.8 M, as well as many exotic indicators such as Price To Sales Ratio of 360, Dividend Yield of 0.0 or PTB Ratio of 0.26. Acasti financial statements analysis is a perfect complement when working with Acasti Pharma Valuation or Volatility modules.
Acasti | Total Current Liabilities |
Latest Acasti Pharma's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Acasti Pharma over the last few years. Total Current Liabilities is an item on Acasti Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Acasti Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Acasti Pharma's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acasti Pharma's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Acasti Total Current Liabilities Regression Statistics
| Arithmetic Mean | 3,657,064 | |
| Geometric Mean | 2,902,859 | |
| Coefficient Of Variation | 87.94 | |
| Mean Deviation | 2,081,151 | |
| Median | 1,816,000 | |
| Standard Deviation | 3,216,183 | |
| Sample Variance | 10.3T | |
| Range | 12.1M | |
| R-Value | 0.31 | |
| Mean Square Error | 10.1T | |
| R-Squared | 0.09 | |
| Significance | 0.26 | |
| Slope | 221,611 | |
| Total Sum of Squares | 144.8T |
Acasti Total Current Liabilities History
About Acasti Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Acasti Pharma income statement, its balance sheet, and the statement of cash flows. Acasti Pharma investors use historical funamental indicators, such as Acasti Pharma's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Acasti Pharma investors may use each financial statement separately, they are all related. The changes in Acasti Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acasti Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Acasti Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Acasti Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 3.9 M | 3.7 M |
Pair Trading with Acasti Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acasti Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Acasti Stock
| 0.61 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.75 | FNA | Paragon 28 | PairCorr |
Moving against Acasti Stock
| 0.78 | KIDS | Orthopediatrics Corp | PairCorr |
| 0.74 | LIVN | LivaNova PLC | PairCorr |
| 0.6 | INGN | Inogen Inc | PairCorr |
| 0.55 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.55 | SGHT | Sight Sciences Trending | PairCorr |
The ability to find closely correlated positions to Acasti Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acasti Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acasti Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acasti Pharma to buy it.
The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acasti Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acasti Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acasti Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Acasti Pharma Correlation against competitors. For more information on how to buy Acasti Stock please use our How to Invest in Acasti Pharma guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Acasti Stock analysis
When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Acasti Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acasti Pharma. If investors know Acasti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acasti Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.68) | Revenue Per Share 0.005 | Return On Assets (0.08) | Return On Equity (0.48) |
The market value of Acasti Pharma is measured differently than its book value, which is the value of Acasti that is recorded on the company's balance sheet. Investors also form their own opinion of Acasti Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acasti Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acasti Pharma's market value can be influenced by many factors that don't directly affect Acasti Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acasti Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Acasti Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acasti Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.